Navigation Links
An Alternative to Warfarin

A new study shows a new drug alternative to warfarin in reducing stroke among people with an irregular and rapid heartbeat. The research shows the drug ximelagatran appears to be as effective as warfarin.//

Warfarin has been used for decades for people at high risk of stroke because of its blood thinning capability. However, some of the drawbacks of warfarin include an increased risk of bleeding and a possible interaction with food and other medications. Another downside is patients must have monthly blood testing and frequent dose changes when they are on warfarin. An international research study led by investigators in Sweden compared the outcomes of patients on warfarin and ximelagatran.

The study included 3,407 patients from Europe, Asia and Australia who suffered from atrial fibrillation, which is an irregular and rapid beating heart, and one or more stroke risk factors. The patients were randomly assigned to receive warfarin or ximelagatran. The patients were followed for 17 months.

Researchers report ximelagatran was at least as effective in reducing the frequency of stroke or blood clots as warfarin. The study also found the rate of stroke, death and major bleeding were similar between both groups. Researchers say these findings show ximelagatran is as effective as warfarin for patients at high risk for stroke.

In an accompanying commentary, researchers from the Netherlands says while ximelagatran may be used for patients with atrial fibrillation, more research is needed to confirm its safety. They say another study looking at the drug clopidogrel may provide yet another alternative to warfarin.
'"/>




Page: 1

Related medicine news :

1. Prince Charles lends support to Alternative Medicine
2. Alternative medicine more popular among HIV positive patients
3. Complementary and Alternative medicine
4. Alternative therapies popular with Parkinsons patients
5. Alternative to blood Transfusions
6. Alternative Therapy in HIV Patients
7. Another Alternative For Diabetics On Insulin
8. The Use Of Alternative Medicine On The Rise
9. Heart Patients Use Alternative Medicine
10. New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years
11. Red Clover- A Future Remedy For Menopause And An Alternative To HRT
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: